Side-by-side financials for GCTK and BSX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GCTK | BSX |
|---|---|---|
| Market cap | - | $71.85 B |
| US-listed rank | - | #236 |
| Revenue (latest FY) | $208.00K | $20.07B |
| Net income (latest FY) | -$19.39M | - |
| Net margin | -9321.2% | - |
| SEC filings | 456 | 1,009 |
Full pages: GlucoTrack, Inc. and BOSTON SCIENTIFIC CORP, or browse the full rankings.